How gut bacteria interact with the immune system in lupus
Role of microbiota-TLR7/8 Interaction in systemic lupus erythematosus
This study is looking at how the bacteria in our gut might affect the immune system and contribute to the development of lupus, with the goal of finding early signs of the disease and new ways to prevent it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10520068 on NIH RePORTER |
What this research studies
This research investigates the role of gut microbiota and its interaction with the immune system in the development of systemic lupus erythematosus (SLE), a chronic autoimmune disease. By studying a pre-clinical model that mimics human SLE, the researchers aim to understand how environmental factors, particularly gut bacteria, can influence the onset of autoimmune responses. The study focuses on identifying early predictors of SLE and the molecular events that trigger inflammation and autoantibody production in the gut, potentially leading to new prevention strategies for the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for systemic lupus erythematosus, particularly women and African Americans, who may have genetic predispositions.
Not a fit: Patients who are not at risk for systemic lupus erythematosus or those who already have advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel strategies for preventing or controlling systemic lupus erythematosus before it manifests clinically.
How similar studies have performed: Other research has shown promising results in understanding the role of gut microbiota in autoimmune diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Vasu, Chenthamarakshan — Medical University of South Carolina
- Study coordinator: Vasu, Chenthamarakshan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.